lilly busy pushing duloxetine cymbalta via depression hurts ad campaign well i suspect drug reps educating doctors wonders i brief literature search via pubmed see hype i found one study compared paroxetine duloxetine found significant benefit duloxetine paroxetine link i could find anything else comparing another medication seems like modest benefits similar rest competitors many purchased much inexpensively generic form issue flooding journals highly similar studies example one study examined effects duloxetine males versus females link another examined effects duloxetine whites versus blacks link wait article comparing whites hispanics link include overlapping authors really warrant separate publications could data i bet database published one article none articles indicated gender race related safety outcomes seems like obvious attempt plaster journals references duloxetine air scientific credibility surround resulting higher prescription rates marketing science collide duck cover apparently strategy working well lilly cymablta sales soaring absence evidence flood journals unimportant findings droves watch cash flow increase